Drawing for MEDONCARE

USPTO serial 79236112

MEDONCARE

Reviewed by CopyMark Law Group

Reg. 5859327Status 709
Filing date
Status date
Registration date
Sep 17, 2019
Examiner
FLETCHER, TRACY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDONCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicinal tonics for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; medicines for human purposes for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; medicinal drinks; capsules for medicines sold empty; pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; chemical-pharmaceutical preparations for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; pre-filled syringes for medical purposes for the treatment of cancer, asthma, and insomnia; medicated lozenges for pharmaceutical purposes; traditional Chinese medicines in the nature of medicinal herbsSECTION 71 - CANCELLED—
010Urological surgical apparatus and instruments; medical sprayers for cleaning gums and teeth used in dentists' offices during dental procedures; aerosol masks for medical purposes; apparatus for use in medical analysis, namely, stethoscopes and X-ray CT scanners; testing apparatus for medical purposes, namely, surgical microscopes and X-ray CT scanners; massage apparatus; medical apparatus and instruments, namely, stethoscopes and X-ray CT scanners; receptacles for applying medicines, namely, insulin injectors sold empty and implantable subcutaneous drug delivery devices sold empty; vibromassage apparatus; fumigation apparatus for medical purposesSECTION 71 - CANCELLED—
030Pastries; condiments, namely, chutney, minced garlic, and prepared horseradish; béchamel sauce; food leavening agents; food flavorings being non-essential oils; vanilla flavorings for food or beverages; vegetal preparations for use as coffee substitutes; tea; tea-based beverages; natural sweetenersSECTION 71 - CANCELLED—
032Non-alcoholic beverages, namely, fruit drinks, soda pop, and drinking water; isotonic beverages; vegetable beveragesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 3, 2026C71TCANCELLED SECTION 71—
Nov 7, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 31, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 13, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 13, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 17, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 7, 2019CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 17, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 5, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jul 4, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jun 12, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 12, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 12, 2019NPUBNOTICE OF PUBLICATION—
May 24, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 14, 2019CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 13, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2019ALIEASSIGNED TO LIE—
Jan 28, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 18, 2018RFNTREFUSAL PROCESSED BY IB—
Aug 2, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2018RFRRREFUSAL PROCESSED BY MPU—
Jul 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 13, 2018DOCKASSIGNED TO EXAMINER—
Jul 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 12, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance